60 Degrees Pharmaceuticals, Inc. (SXTP)
3.05
-0.19
(-5.86%)
USD |
NASDAQ |
Feb 20, 16:00
3.05
0.00 (0.00%)
After-Hours: 20:00
60 Degrees Pharmaceuticals EPS Diluted (Quarterly) : -2.659 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Greenwich LifeSciences, Inc. | -0.3044 |
| Abbott Laboratories | 1.017 |
| GoodRx Holdings, Inc. | 0.0032 |
| Moderna, Inc. | -2.107 |
| Revolution Medicines, Inc. | -1.613 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.316M |
| Revenue (Quarterly) | 0.5286M |
| Total Expenses (Quarterly) | 2.844M |
| Enterprise Value | 9.693M |
| Gross Profit Margin (Quarterly) | -1.72% |
| Profit Margin (Quarterly) | -438.1% |
| Earnings Yield | -806.8% |
| Normalized Earnings Yield | -794.81 |